Formulated for major depressive disorder and anxiety to manage emotional health and support symptom relief.
Mechanism of Action
Sertraline selectively inhibits the presynaptic reuptake of serotonin (5-HT). This increases synaptic serotonin availability, which enhances serotonergic transmission to regulate mood, anxiety, and compulsive behaviors.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
26 hours (half-life)
Contraindications
Concurrent use of MAO inhibitors, Concurrent use of pimozide, Concurrent use of disulfiram, Hypersensitivity to sertraline
Information related to Sertraline is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.